Newsfile Corp
16 Nov 2026, 11:50 UTC · 13h ago
Kaplan Fox Encourages Tenax Therapeutics, Inc. (TENX) Investors to Contact the Firm Before the Deadline on December 28, 2026 for a Leadership Role
Impact · against what's priced in
Tenax Therapeutics faces potential financial liabilities and governance distraction following the filing of a class action lawsuit covering a nearly three-year period. This introduces unexpected legal risk and potential cash outflows that may impact the company's balance sheet.
- TENX−0.30
No priced-in read yet





